AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.100
-0.040 (-3.51%)
At close: Jul 24, 2025, 4:00 PM
1.080
-0.020 (-1.82%)
After-hours: Jul 24, 2025, 7:08 PM EDT
AN2 Therapeutics Employees
AN2 Therapeutics had 22 employees as of December 31, 2024. The number of employees decreased by 19 or -46.34% compared to the previous year.
Employees
22
Change (1Y)
-19
Growth (1Y)
-46.34%
Revenue / Employee
n/a
Profits / Employee
-$2,061,500
Market Cap
33.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22 | -19 | -46.34% |
Dec 31, 2023 | 41 | 5 | 13.89% |
Dec 31, 2022 | 36 | 14 | 63.64% |
Dec 31, 2021 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ANTX News
- 1 day ago - AN2 Therapeutics and DNDi Collaborate on Clinical Development of Promising New Oral Compound to Treat Chronic Chagas Disease - Business Wire
- 24 days ago - AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole - Business Wire
- 2 months ago - AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference - Business Wire
- 2 months ago - AN2 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business and Scientific Highlights - Business Wire
- 3 months ago - AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline - Business Wire
- 3 months ago - AN2 Therapeutics to Participate in Citizens JMP Life Sciences Conference - Business Wire
- 4 months ago - AN2 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business and Scientific Highlights - Business Wire
- 5 months ago - AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference - Business Wire